#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17260	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2073	824.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1399	1399	C	994	C	928	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17260	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2073	824.1	0	HET	.	.	.	A69G	.	69	69	A	284	284	A	984	A,G	728,193	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31484	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3681	853.4	0	.	n	.	0	T695C	SNP	695	695	T	1106	1106	C	937	C	881	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31484	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3681	853.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1748	1748	A	1041	A	973	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31484	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3681	853.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2382	2382	C	1006	C	929	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31484	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3681	853.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3008	3008	T	1049	T,C	755,229	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31484	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3681	853.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2456	2456	A	1007	A	935	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2370	folP	855	855	100.0	folP.l15.c30.ctg.1	1577	149.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1112	1114	AGC	247;247;251	A;G;C,T	225;228;229,1	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5894	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3550	165.5	1	SNP	p	S91F	1	.	.	271	273	TTC	647	649	TTC	201;201;202	T;T;C	181;183;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5894	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3550	165.5	1	SNP	p	D95G	1	.	.	283	285	GGC	659	661	GGC	183;182;182	G;G;C	171;166;169	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5894	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3550	165.5	1	SNP	p	G95N	0	.	.	283	285	GGC	659	661	GGC	183;182;182	G;G;C	171;166;169	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1882	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1270	147.1	1	SNP	p	G45D	0	.	.	133	135	GGC	442	444	GGC	220;222;219	G;G;C	205;204;202	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	982	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	940	103.0	0	.	n	.	0	A197.	DEL	197	197	A	539	539	A	230	A	219	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6086	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	204.9	1	SNP	p	D86N	0	.	.	256	258	GAC	660	662	GAC	245;248;251	G;A;C	233;229;237	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6086	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	204.9	1	SNP	p	R87I	0	.	.	259	261	CGT	663	665	CGT	251;251;252	C,A;G;T	238,1;237;237	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6086	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	204.9	1	SNP	p	R87W	0	.	.	259	261	CGT	663	665	CGT	251;251;252	C,A;G;T	238,1;237;237	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6086	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	204.9	1	SNP	p	S87R	1	.	.	259	261	CGT	663	665	CGT	251;251;252	C,A;G;T	238,1;237;237	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6086	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	204.9	1	SNP	p	S88P	0	.	.	262	264	TCC	666	668	TCC	251;252;249	T;C;C	233;240;236	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5160	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2783	184.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1554	1556	GGC	247;247;242	G;G;C	231;232;222	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1194	1196	GCA	266;267;270	G;C;A	237;236;244	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1197	1199	ATC	272;276;279	A;T;C	248;252;251	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1209	1211	GTG	265;265;265	G;T,A;G	239;236,1;239	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1209	1211	GTG	265;265;265	G;T,A;G	239;236,1;239	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1713	1715	ACC	242;240;238	A;C;C	225;222;222	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1767	1769	GCG	227;228;226	G;C,G;G	198;179,1;182	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1767	1769	GCG	227;228;226	G;C,G;G	198;179,1;182	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1890	1892	AGC	223;222;219	A;G;C	209;206;205	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1899	1901	GGC	211;206;206	G;G;C	198;192;192	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4892	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2298	211.3	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1917	1919	CCG	168;173;169	C,G;C;GCCC,GGCCCC	114,2;117;107,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6540	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3001	217.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1605	1607	CCG	271;273;272	C;C;G	247;257;250	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2700	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1803	148.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	653	653	C	192	C	176	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	500	502	GAA	248;249;244	G;A;A	235;237;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	788	790	GAT	234;233;237	G;A;T	225;224;228	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	911	913	TCA	250;251;251	T;C;A	238;240;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	D212Y	NONSYN	634	636	GAT	1022	1024	TAT	242;244;247	T;A;T,A	231;233;235,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1040	1042	GTC	239;241;240	G;T;C	228;229;232	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1052	1054	TCT	243;241;241	T;C;T	233;233;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1370	1372	GCA	281;279;283	G;C,A;A	260;256,1;262	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	1	SNP	p	G120K	1	.	.	358	360	AAG	746	748	AAG	249;248;252	A;A;G	227;227;232	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	1	SNP	p	A121D	1	.	.	361	363	GAC	749	751	GAC	250;246;245	G;A;C	228;224;225	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3172	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1794	176.0	1	SNP	p	D121N	0	.	.	361	363	GAC	749	751	GAC	250;246;245	G;A;C	228;224;225	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11954	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4912	242.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1372	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	876	154.6	1	SNP	p	V57M	1	.	.	169	171	ATG	442	444	ATG	261;258;259	A;T,C;G	248;245,1;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
